Aldeyra Therapeutics, Inc. (ALDX)

Aldeyra Therapeutics, Inc. (ALDX) scores 46 out of 100 on boothcheck's 11-model valuation framework. Verdict: Avoid The estimated fair value is $411318.63, representing a 18444682% margin of safety. Quantitative score: 64/100. Qualitative score: 20/100.

Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.

View full ALDX analysis on boothcheck